Resultats de la cerca - Dominic Curran

  • Mostrar 1 - 2 resultats de 2
Refinar resultats
  1. 1
    Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

    Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study per Sumanta K. Pal, Bradley A. McGregor, Cristina Suárez, Che‐Kai Tsao, William Kelly, Ulka N. Vaishampayan, Lance C. Pagliaro, Benjamin L. Maughan, Yohann Loriot, Daniel Castellano, Sandy Srinivas, Rana R. McKay, Robert Dreicer, Thomas E. Hutson, Sarita Dubey, Scott Werneke, Ashok Panneerselvam, Dominic Curran, Christian Scheffold, Toni K. Choueiri, Neeraj Agarwal

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy

    CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy per Joel W. Neal, Nick Pavlakis, Sang‐We Kim, Yasushi Goto, Sun Min Lim, Giannis Mountzios, Elena Fountzilas, Anastasia Mochalova, Daniel C. Christoph, Alessandra Bearz, Xavier Quantin, Ramón Palmero, Vladan Antic, Elaine W. Chun, Tirupathi Rao Edubilli, Ya‐Chen Lin, Mahrukh Huseni, Marcus Ballinger, Vilma Graupner, Dominic Curran, Piet Vervaet, Thomas Newsom-Davis

    Publicat 2024
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: